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Background: : The beneficial effect of percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) remains 
matter of debate for non STEMI (NSTEMI). The aim of this study was to evaluate the effect of PCI on outcomes of STEMI and NSTEMI patients using 
AMI-Florence 2 data.
Methods: AMI-Florence 2 was a prospective observational registry including all the Florence area residents who experienced STEMI and NSTEMI 
from April 14, 2008 to April 13, 2009, admitted to hospital within 24 hours from symptom onset. Life status after hospital discharge was assessed at 
6 months by consulting the Registry Office of the municipalities of residence. 
Results: A total of 1557 consecutive events (62% men) with STEMI (n=564, 36%) and NSTEMI (n=993, 64%) were included. The median delay from 
symptom onset to in-hospital presentation was shorter in patients with STEMI vs. NSTEMI (120 vs. 142 min; P< 0.003). Among STEMI patients the 
median door-to-balloon time was 111 min (<90 min: 40%). STEMI patients were more likely to undergo PCI during hospital stay (81.6 vs. 47.1%; P < 
0.0001). The majority of NSTEMI patients underwent early PCI (<72 h): 74% (urgent:1.5%). In-hospital mortality was higher for STEMI in comparison 
to NSTEMI patients (9.1 vs. 4.1%; P<.0001). At 6-month , mortality was 13.9% for STEMI and 13.2% for NSTEMI patients (P=0.681). The strongest 
predictors of 6-month mortality were advanced age, Killip class >1, and cancer (<5-year) for both STEMI and NSTEMI patients, and stroke, heart 
failure and renal failure for NSTEMI patients only. The beneficial effect of PCI in terms of 6-month mortality reduction was similar in STEMI and 
NSTEMI patients (HR 0.55; 95% CI 0.34 -0.89 vs HR 0.50; 95% CI 0.32-0.79, respectively).
Conclusions: Patients with STEMI and NSTEMI have similar beneficial effect from PCI. However, different pathophysiological mechanisms may 
explain the different mortality course which is higher in the hospital phase for STEMI patients likely related to the myocardial effects of the occlusive 
coronary thrombus, whereas it is higher in the subsequent 6-month follow-up for NSTEMI patients likely related to the baseline worse risk profile and 
to the comorbilities.
